Risk factors for coronary artery disease in non-insulin dependent diabetes mellitus: United Kingdom Prospective Diabetes Study (UKPDS: 23)
- PMID: 9549452
- PMCID: PMC28484
- DOI: 10.1136/bmj.316.7134.823
Risk factors for coronary artery disease in non-insulin dependent diabetes mellitus: United Kingdom Prospective Diabetes Study (UKPDS: 23)
Abstract
Objective: To evaluate baseline risk factors for coronary artery disease in patients with type 2 diabetes mellitus.
Design: A stepwise selection procedure, adjusting for age and sex, was used in 2693 subjects with complete data to determine which risk factors for coronary artery disease should be included in a Cox proportional hazards model.
Subjects: 3055 white patients (mean age 52) with recently diagnosed type 2 diabetes mellitus and without evidence of disease related to atheroma. Median duration of follow up was 7.9 years. 335 patients developed coronary artery disease within 10 years.
Outcome measures: Angina with confirmatory abnormal electrocardiogram; non-fatal and fatal myocardial infarction.
Results: Coronary artery disease was significantly associated with increased concentrations of low density lipoprotein cholesterol, decreased concentrations of high density lipoprotein cholesterol, and increased triglyceride concentration, haemoglobin A1c, systolic blood pressure, fasting plasma glucose concentration, and a history of smoking. The estimated hazard ratios for the upper third relative to the lower third were 2.26 (95% confidence interval 1.70 to 3.00) for low density lipoprotein cholesterol, 0.55 (0.41 to 0.73) for high density lipoprotein cholesterol, 1.52 (1.15 to 2.01) for haemoglobin A1c, and 1.82 (1.34 to 2.47) for systolic blood pressure. The estimated hazard ratio for smokers was 1.41 (1.06 to 1.88).
Conclusion: A quintet of potentially modifiable risk factors for coronary artery disease exists in patients with type 2 diabetes mellitus. These risk factors are increased concentrations of low density lipoprotein cholesterol, decreased concentrations of high density lipoprotein cholesterol, raised blood pressure, hyperglycaemia, and smoking.
Figures
Comment in
-
Combined high blood pressure and glucose in type 2 diabetes: double jeopardy. British trial shows clear effects of treatment, especially blood pressure reduction.BMJ. 1998 Sep 12;317(7160):693-4. doi: 10.1136/bmj.317.7160.693. BMJ. 1998. PMID: 9732334 Free PMC article. No abstract available.
Similar articles
-
LDL-cholesterol versus non-HDL-to-HDL-cholesterol ratio and risk for coronary heart disease in type 2 diabetes.Eur J Prev Cardiol. 2014 Nov;21(11):1420-8. doi: 10.1177/2047487313494292. Epub 2013 Jun 17. Eur J Prev Cardiol. 2014. PMID: 23774274
-
Evaluation of low-density lipoprotein particle number distribution in patients with type 2 diabetes mellitus with low-density lipoprotein cholesterol <50 mg/dl and non-high-density lipoprotein cholesterol <80 mg/dl.Am J Cardiol. 2012 Sep 1;110(5):662-5. doi: 10.1016/j.amjcard.2012.04.046. Epub 2012 May 22. Am J Cardiol. 2012. PMID: 22621796
-
Serum level of triglycerides is a potent risk factor comparable to LDL cholesterol for coronary heart disease in Japanese patients with type 2 diabetes: subanalysis of the Japan Diabetes Complications Study (JDCS).J Clin Endocrinol Metab. 2011 Nov;96(11):3448-56. doi: 10.1210/jc.2011-0622. Epub 2011 Aug 24. J Clin Endocrinol Metab. 2011. PMID: 21865372
-
Epidemiologic evidence for high-density lipoprotein cholesterol as a risk factor for coronary artery disease.Am J Cardiol. 2001 Dec 20;88(12A):9N-13N. doi: 10.1016/s0002-9149(01)02146-4. Am J Cardiol. 2001. PMID: 11788124 Review.
-
The epidemiology of low levels of high-density lipoprotein cholesterol in patients with and without coronary artery disease.Am J Cardiol. 2000 Dec 21;86(12A):11L-14L. doi: 10.1016/s0002-9149(00)01462-4. Am J Cardiol. 2000. PMID: 11374848 Review.
Cited by
-
Non-alcoholic fatty liver disease: A major challenge in type 2 diabetes mellitus (Review).Exp Ther Med. 2020 Sep;20(3):2387-2391. doi: 10.3892/etm.2020.8882. Epub 2020 Jun 12. Exp Ther Med. 2020. PMID: 32765720 Free PMC article. Review.
-
Review article: the impact of liver-directed therapies on the atherogenic risk profile in non-alcoholic steatohepatitis.Aliment Pharmacol Ther. 2020 Aug;52(4):619-636. doi: 10.1111/apt.15935. Epub 2020 Jul 8. Aliment Pharmacol Ther. 2020. PMID: 32638417 Free PMC article. Review.
-
Age- and Gender-Related Differences in LDL-Cholesterol Management in Outpatients with Type 2 Diabetes Mellitus.Int J Endocrinol. 2015;2015:957105. doi: 10.1155/2015/957105. Epub 2015 Mar 19. Int J Endocrinol. 2015. PMID: 25873960 Free PMC article.
-
Additive effects of glycaemia and blood pressure exposure on risk of complications in type 2 diabetes: a prospective observational study (UKPDS 75).Diabetologia. 2006 Aug;49(8):1761-9. doi: 10.1007/s00125-006-0297-1. Epub 2006 May 31. Diabetologia. 2006. PMID: 16736131 Clinical Trial.
-
Gemfibrozil decreases atherosclerosis in experimental diabetes in association with a reduction in oxidative stress and inflammation.Diabetologia. 2006 Apr;49(4):766-74. doi: 10.1007/s00125-005-0102-6. Epub 2006 Feb 4. Diabetologia. 2006. PMID: 16463048
References
-
- Garcia MJ, McNamara PM, Gordon T, Kannell WB. Morbidity and mortality in diabetics in the Framingham population. Sixteen year follow-up. Diabetes. 1974;23:105–111. - PubMed
-
- Panzram G. Mortality and survival in type 2 (non-insulin-dependent) diabetes mellitus. Diabetologia. 1987;30:123–131. - PubMed
-
- United Kingdom Prospective Diabetes Study Group. UKPDS 17. A nine-year update of a randomized, controlled trial on the effect of improved metabolic control on complications in non-insulin-dependent diabetes mellitus. Ann Intern Med. 1996;124:136–145. - PubMed
-
- Stamler J, Vaccaro O, Neaton JD, Wentworth D. Diabetes, other risk factors, and 12 year cardiovascular mortality for men screened in the Multiple Risk Factor Intervention Trial. Diabetes Care. 1993;16:434–444. - PubMed
-
- Gall MA, Borch-Johnsen K, Hougaard P, Nielsen FS, Parving HH. Albuminuria and poor glycaemic control predict mortality in NIDDM. Diabetes. 1995;44:1303–1309. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical